NEW YORK, May 26, 2011 /PRNewswire/ — OTC Markets
Group Inc. (OTCQX: OTCM), the financial information and
technology services company that provides the world’s largest
electronic marketplace for broker-dealers to trade unlisted stocks,
today announced that Verisante
Technology Inc. (TSX.V: VRS; OTCQX: VRSEF), a medical device
company committed to commercializing innovative systems for the
early detection of cancer, is now trading on the OTC market’s
highest tier, OTCQX®.
(Logo: http://photos.prnewswire.com/prnh/20110118/MM31963LOGO)
Verisante began trading today on the OTC market’s prestigious
tier, OTCQX International. Investors can find current
financial disclosure and Real-Time Level 2 quotes for the Company
on www.otcqx.com and www.otcmarkets.com.
“The superior information and visibility of the OTCQX
marketplace allows companies to efficiently build investor
confidence and expand their shareholder base,” said R. Cromwell
Coulson, President and Chief Executive Officer of OTC Markets
Group. “We are pleased to welcome Verisante Technology to
OTCQX.”
Hodgson Russ LLP will serve as Verisante’s Principal American
Liaison (“PAL”) on OTCQX, responsible for providing guidance on
OTCQX requirements.
About Verisante Technology Inc.
Verisante
Technology Inc. (TSX.V: VRS; OTCQX: VRSEF) trades in the United
States on OTCQX under the symbol “VRSEF”. Verisante is a medical
device company committed to commercializing innovative systems for
the early detection of cancer. Our exclusive platform technology
allows us to develop and offer a range of compact, non-invasive
cancer detection devices that offe
‘/>”/>
SOURCE